Free Trial

Evaxion Biotech A/S (EVAX) Short Interest Ratio & Short Volume

Evaxion Biotech A/S logo
$1.31 0.00 (-0.08%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$1.31 +0.00 (+0.08%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evaxion Biotech A/S Short Interest Data

Evaxion Biotech A/S (EVAX) has a short interest of 41,800 shares, representing 3.29% of the float (the number of shares available for trading by the public). This marks a 86.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 598,572 shares to cover all short positions.

Current Short Interest
41,800 shares
Previous Short Interest
22,400 shares
Change Vs. Previous Month
+86.61%
Dollar Volume Sold Short
$77,330.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
1,403,000 shares
Float Size
1,270,000 shares
Short Percent of Float
3.29%
Today's Trading Volume
62,885 shares
Average Trading Volume
598,572 shares
Today's Volume Vs. Average
11%
Short Selling Evaxion Biotech A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Evaxion Biotech A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EVAX Short Interest Over Time

EVAX Days to Cover Over Time

EVAX Percentage of Float Shorted Over Time

Evaxion Biotech A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202541,800 shares $77,330.00 +86.6%3.3%0 $1.85
3/15/202522,400 shares $39,872.00 -74.2%2.1%0 $1.78
2/28/202586,700 shares $168,198.00 +48.0%8.2%0 $1.94
2/15/202558,600 shares $145,914.00 -52.9%5.5%0 $2.49
1/31/2025124,500 shares $305,025.00 +21.7%N/A0.1 $2.45
1/15/2025102,300 shares $336,567.00 -89.6%N/A0.1 $3.29
12/31/2024980,100 shares $4.14 million +709.3%N/A2.9 $4.23
12/15/2024121,100 shares $138,054.00 +285.7%N/A2 $1.14
11/30/202431,400 shares $52,124.00 -12.8%N/A0.6 $1.66
11/15/202436,000 shares $53,280.00 -31.6%N/A0.7 $1.48
10/31/202452,600 shares $137,812.00 -22.0%N/A1.1 $2.62
10/15/202467,400 shares $181,306.00 -21.1%N/A1.4 $2.69
9/30/202485,400 shares $265,594.00 +286.4%N/A1.7 $3.11
9/15/202422,100 shares $66,300.00 -35.2%N/A0.6 $3.00
8/31/202434,100 shares $104,005.00 -24.9%N/A0.8 $3.05
8/15/202445,400 shares $135,746.00 +9.4%N/A1.1 $2.99
7/31/202441,500 shares $118,690.00 -20.4%N/A1.1 $2.86
7/15/202452,100 shares $164,115.00 -40.8%N/A1.4 $3.15
6/30/202488,000 shares $255,200.00 +93.8%N/A2.3 $2.90
6/15/202445,400 shares $140,740.00 +6.3%N/A1 $3.10
5/31/202442,700 shares $156,709.00 -10.9%N/A1.5 $3.67
5/15/202447,900 shares $180,104.00 -10.0%N/A1.4 $3.76
4/30/202453,200 shares $222,908.00 +11.3%N/A1 $4.19
4/15/202447,800 shares $195,980.00 +12.2%N/A0.1 $4.10
3/31/202442,600 shares $136,320.00 -0.9%N/A0.1 $3.20
3/15/202443,000 shares $128,570.00 +56.4%N/A0.1 $2.99
2/29/202427,500 shares $99,000.00 +41.8%N/A0 $3.60
2/15/202419,400 shares $80,510.00 -61.0%N/A0 $4.15
1/31/202449,800 shares $195,714.00 +325.6%N/A0.1 $3.93
1/15/202411,700 shares $93,483.00 -92.5%N/A0.4 $7.99
12/31/2023155,800 shares $106,832.06 -9.1%N/A1.7 $0.69
12/15/2023171,400 shares $113,124.00 -26.9%N/A1.8 $0.66
11/30/2023234,300 shares $187,205.70 +7.8%N/A1.5 $0.80
11/15/2023217,400 shares $161,963.00 -22.8%N/A1.5 $0.75
10/31/2023281,600 shares $315,392.00 -22.5%N/A2.1 $1.12
10/15/2023363,400 shares $308,526.60 -31.6%N/A3.1 $0.85
9/30/2023531,500 shares $442,739.50 +118.9%N/A4.6 $0.83
9/15/2023242,800 shares $182,609.88 +38.5%N/A2.2 $0.75
8/31/2023175,300 shares $145,516.53 -23.8%N/A2.8 $0.83
8/15/2023230,000 shares $233,059.00 -30.7%N/A1.1 $1.01
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

7/31/2023331,700 shares $411,308.00 -9.9%N/A1.5 $1.24
7/15/2023368,000 shares $463,680.00 -15.6%N/A1.8 $1.26
6/30/2023436,200 shares $567,060.00 -18.4%N/A1.9 $1.30
6/15/2023534,300 shares $694,590.00 +110.1%N/A2.2 $1.30
5/31/2023254,300 shares $386,536.00 -4.0%N/A1.1 $1.52
5/15/2023264,800 shares $415,736.00 +5.5%N/A2.8 $1.57
4/30/2023251,100 shares $316,386.00 -34.3%N/A0.7 $1.26
4/15/2023382,100 shares $596,076.00 -12.1%N/A1 $1.56
3/31/2023434,700 shares $491,211.00 +24.2%N/A1 $1.13
3/15/2023350,100 shares $378,108.00 +31.6%N/A0.6 $1.08
2/28/2023266,100 shares $409,794.00 -20.6%N/A0.4 $1.54
2/15/2023335,200 shares $526,264.00 +74.6%N/A0.6 $1.57
1/31/2023192,000 shares $309,120.00 -11.0%N/A0.3 $1.61
1/15/2023215,800 shares $334,490.00 +572.3%N/A0.7 $1.55
12/30/202232,100 shares $56,977.50 -9.8%N/A0.2 $1.78
12/15/202235,600 shares $71,200.00 +16.0%N/A0.5 $2.00
11/30/202230,700 shares $66,926.00 -26.0%N/A0 $2.18
11/15/202241,500 shares $97,940.00 -39.4%N/A0.1 $2.36
10/31/202268,500 shares $178,100.00 -45.8%N/A0.1 $2.60
10/15/2022126,300 shares $368,796.00 -36.5%N/A0.2 $2.92
9/30/2022198,800 shares $522,844.00 +9.7%N/A0.3 $2.63
9/15/2022181,200 shares $373,272.00 -0.7%N/A0.2 $2.06
8/31/2022182,400 shares $428,640.00 -2.6%N/A5.2 $2.35
8/15/2022187,200 shares $548,496.00 -3.8%N/A4.6 $2.93
7/31/2022194,600 shares $595,476.00 +6.5%N/A0.5 $3.06
7/15/2022182,700 shares $442,134.00 -9.8%N/A0.5 $2.42
6/30/2022202,600 shares $388,992.00 +13.1%N/A0.5 $1.92
6/15/2022179,100 shares $300,888.00 +3.0%N/A0.5 $1.68
5/31/2022173,900 shares $340,844.00 -35.6%N/A0.5 $1.96
5/15/2022270,100 shares $469,974.00 +4,810.9%N/A0.7 $1.74
4/30/20225,500 shares $15,400.00 -41.5%N/A0.2 $2.80
4/15/20229,400 shares $27,072.00 -34.7%N/A0.2 $2.88
3/31/202214,400 shares $43,632.00 +84.6%N/A0.2 $3.03
3/15/20227,800 shares $20,826.00 +116.7%N/A0.1 $2.67
2/28/20223,600 shares $10,944.00 -82.0%N/A0 $3.04
2/15/202220,000 shares $63,800.00 -58.6%N/A0.1 $3.19
1/31/202248,300 shares $151,662.00 -3.0%N/A0.2 $3.14
1/15/202249,800 shares $203,682.00 +28.7%N/A0 $4.09
12/31/202138,700 shares $171,054.00 +25.7%N/A0 $4.42
12/15/202130,800 shares $126,588.00 +37.5%N/A0 $4.11
11/30/202122,400 shares $104,384.00 -57.1%N/A0 $4.66
11/15/202152,200 shares $324,162.00 +78.2%N/A0.1 $6.21
10/29/202129,300 shares $222,973.00 +229.2%N/A0 $7.61
10/15/20218,900 shares $70,488.00 -77.2%N/A0.1 $7.92
9/30/202139,000 shares $375,960.00 -27.9%N/A0.4 $9.64
9/15/202154,100 shares $444,161.00 +57.7%N/A0.6 $8.21
8/31/202134,300 shares $223,979.00 -2.8%N/A0.3 $6.53
8/13/202135,300 shares $205,093.00 No ChangeN/A0.5 $5.81

EVAX Short Interest - Frequently Asked Questions

What is Evaxion Biotech A/S's current short interest?

Short interest is the volume of Evaxion Biotech A/S shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 41,800 shares of EVAX short. 3.29% of Evaxion Biotech A/S's shares are currently sold short. Learn More on Evaxion Biotech A/S's current short interest.

Which institutional investors are shorting Evaxion Biotech A/S?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evaxion Biotech A/S: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Evaxion Biotech A/S?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.29% of Evaxion Biotech A/S's floating shares are currently sold short.

Is Evaxion Biotech A/S's short interest increasing or decreasing?

Evaxion Biotech A/S saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 41,800 shares, an increase of 86.6% from the previous total of 22,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Evaxion Biotech A/S's float size?

Evaxion Biotech A/S currently has issued a total of 1,403,000 shares. Some of Evaxion Biotech A/S's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Evaxion Biotech A/S currently has a public float of 1,270,000 shares.

How does Evaxion Biotech A/S's short interest compare to its competitors?

3.29% of Evaxion Biotech A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evaxion Biotech A/S: Cyclerion Therapeutics, Inc. (2.55%), ProPhase Labs, Inc. (6.29%), Biofrontera Inc. (0.75%), Mainz Biomed (4.68%), Aytu BioPharma, Inc. (1.96%), Alzamend Neuro, Inc. (5.67%), Lipella Pharmaceuticals Inc. (1.09%), TransCode Therapeutics, Inc. (12.15%), GT Biopharma, Inc. (3.24%), Portage Biotech Inc. (50.72%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Evaxion Biotech A/S stock?

Short selling EVAX is an investing strategy that aims to generate trading profit from Evaxion Biotech A/S as its price is falling. EVAX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Evaxion Biotech A/S?

A short squeeze for Evaxion Biotech A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVAX, which in turn drives the price of the stock up even further.

How often is Evaxion Biotech A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVAX, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:EVAX) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners